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Abstract
Gene delivery vectors based on adenovirus, particularly human adenovirus serotype 5 (hAd5) have great potential
for the treatment of variety of diseases. However, the tropism of hAd5 needs to be modified to achieve tissue- or
cell- specific therapies for the successful application of this vector system to clinic. Here, we modified hAd5 tropism
by replacing the fiber knob which contains the coxsackievirus B and adenovirus receptor (CAR)-binding sites with a
biotin acceptor peptide, a truncated form of Propionibacterium shermanii 1.3 S transcarboxylase domain (PSTCD), to
enable metabolically biotinylation of the virus. We demonstrate here that the new adenovirus no longer shows
CAR-dependent cell uptake and transduction. When metabolically biotinylated and avidin-coated, it forms a nano-
complex that can be retargeted to distinct cells using biotinylated antibodies. This vector may prove useful in the
path towards achieving targeted gene delivery.
Findings
The hAd5-based vector remains one of the most popu-
lar vector systems for gene delivery and cancer gene
therapy. However, the ubiquitous expression of adeno-
viral primary receptor CAR in many tissues and the pre-
dominant liver tropism of the vector after systemic
administration limit the application of hAd5 vector to
clinical use [1]. Therefore, strategies to re-direct hAd5
infection and to decrease the rapid uptake of the virus
by the reticuloendothelial system (RES) will be essential
for many gene therapy applications. The hAd5 binds to
most cell types through the interaction of its fiber knob
domain with cell surface CAR [2]. Retargeting of the
hAd5 vector appears to be more effective when the
transduction mediated by retargeting ligands is directed
through the fiber protein [3]. The adenoviral capsid pro-
teins, especially fiber knob and hexon, associate with
blood factors and mediate hepatocyte transduction
in vivo [4-8]. The binding of hAd5 hexon protein with
coagulation factor FX plays a major role in hepatocyte
infection in vivo [4-6]. Single point mutation within
the hexon hypervariable regions effectively blocks
FX-mediated adenoviral hepatocyte transduction in vitro
and in vivo [7]. The hAd5 fiber knob domain binds
coagulation factor IX and complement component
C4-binding protein that bridge the virus to cognate
receptors on hepatocytes [8]. In the same study, a modi-
fied adenoviral vector with fiber knob mutations was
shown to have less accumulation in both hepatocyte and
Kupffer cells. Therefore, both the fiber and hexon pro-
teins need to be modified to retarget adenoviral vector
away from the liver.
In the study reported here, we have ablated the native
tropism of hAd5 by removing the fiber knob and part of
the central shaft. We have added to the short fiber a trun-
cated form of PSTCD as a biotin acceptor protein to allow
the virus to be metabolically biotinylated. We demon-
strated here that the N-terminal tail and 9 shaft repeats
fused with PSTCD protein can be successfully incorpo-
rated into the adenovirus particles to form the required
trimer and to be biotinylated. The resulting metabolically
biotinylated adenovirus can be redirected to specific cells
depending on the biotinylated antibody used.
The hAd5 fiber proteins exist as homotrimers which
contains an N-terminal tail, a central shaft comprising 21
repeating sequences of 15 amino acids, and a C-terminal
globular knob domain [9]. Without the knob domain, a
shortened fiber protein 9R containing the N-terminal tail
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trimers and support peptide fusion [10]. Also a truncated
form of PSTCD fused to the C-terminus of the fiber pro-
tein can be efficiently biotinylated by human holocarbox-
ylase synthetase presented in HEK-293 cells [11]. Here,
we fused the 70-amino-acid PSTCD on the 9R modified
fiber. We found that the 9R modified fiber tolerates the
large protein addition and remains fiber trimerization.
The fused construction could readily be biotinylated in
mammalian cells (data not shown). We then replaced the
wild type fiber gene in hAd5 vector with the 9R or
9RPSTCD modified fiber gene to generate Ad.9R-GFP
and Ad.9RPSTCD-GFP viral vectors using the Adeasy
system [12] with modifications. Ad.Control-GFP which
was E1/E3 deleted viral vector expressing GFP was con-
structed as previously described [13]. The structure orga-
nization of each vector is illustrated in Figure 1A.
The presence of the modified fiber and the successful
biotinylation of the fiber were confirmed using immuno-
blotting analysis. As shown in Figure 1B, all 3 fiber pro-
teins trimerized and assembled onto the hAd5 viral
particles, but only the 9RPSTCD protein could be bioti-
nylated. Thus, the 9RPSTCD modified fiber assembled
onto hAd5 particles and was metabolically biotinylated
during virus production.
We then began to characterize our new viral vectors
functionally. The interaction of the Ad5 fiber knob with
cell surface CAR mainly determines the tropism of the
virus in cell culture. Therefore, both the Ad.9R-GFP and
Ad.9RPSTCD-GFP vectors should have decreased trans-
duction efficiency to a cell line that has high expression
level of CAR because the complete knob domain is
deleted. We transduced MA104/APP cells [14] with
indicated viral vectors at different multiplicity of infec-
tion (MOI). The cells were collected and GFP positive
cells were counted by flow cytometry after 24 h. As
shown in Figure 2A, unlike the unmodified control
virus, both the Ad.9R-GFP and the Ad.9RPSTCD-GFP
vectors failed to transduce MA104/APP cells. Thus, the
normal tropism and transduction efficiency were suc-
cessfully ablated in the new vectors.
To test the possibility that the Ad.9RPSTCD-GFP vector
could be retargeted through biotin-avidin-biotin interac-
tion in cells, we first pre-incubated the Ad9RPSTCD-GFP
vector with neutravidin to generate the Ad.9RPSTCD-GFP
(avidin) vector. This neutravidin-coated vector was puri-
fied by cesium chloride (CsCl) density gradient centrifuga-
tion. We then chemically biotinylated the surface proteins
of MA104/APP cells and incubated them with the
Ad.9RPSTCD-GFP(avidin) vector at different MOI before
assessing transduction by counting GFP-positive cells. As
shown in Figure 2B, the Ad.9RPSTCD-GFP(avidin) virus
only transduced cells with biotinylated cell surface pro-
teins (~ 50% cells expressed GFP at MOI 1000). If cells
were not biotinylated, Ad.9RPSTCD-GFP(avidin) trans-
duced less than 10% of the cells at the same MOI. The
Ad.9RPSTCD-GFP virus could not, alone without the avi-
din coating, transduce native or surface-biotinylated cells,
indicating that the biotin-avidin-biotin interaction is
essential for efficient transduction.
Next, we tested whether the Ad.9RPSTCD-GFP(avi-
din) vector could be efficiently retargeted to cells by
using biotinylated antibodiesa g a i n s tas p e c i f i cc e l ls u r -
face protein. We chemically biotinylated monoclonal
antibody J310 which recognizes rat aminopeptidase
P (APP) [15], and monoclonal antibody J120, which
reacts specifically with CD34 [16]. Two cell lines,
MA104 and its derivative cell line MA104/APP which
stably expresses rat APP [14], were incubated first with
biotinylated J310 and then with the Ad.9RPSTCD-GFP
(avidin) vector. The transduced GFP positive cells were
counted. Figure 3A shows that the Ad.9RPSTCD-GFP
(avidin) transduced MA104/APP cells only when the
cells were first incubated with the biotinylated J310 anti-
body. This vector did not effectively transduce MA104
cells not expressing APP even though they were still
incubated with the biotinylated J310 antibody. Next, we
performed same experiment using rat aortic endothelial
cells (RAEC) that express abundant CD34 but not APP.
The Ad.9RPSTCD-GFP(avidin) virus was able to suc-
cessfully transduce RAEC when these cells were pre-
incubated with chemically biotinylated J120 antibody
but not with biotinylated J310 or no antibody at all (Fig-
ure 3B). For both experiments, we used surface-biotiny-
lated cells as a positive control and noted that the
transduction efficiency of specific antibodies-redirected
vectors were very similar to it. These results further
confirmed that viral targeting and transduction efficacy
can be quite antibody-specific.
As a last test, we wanted to form preconjugated bioti-
nylated adenovirus-avidin-biotinylated antibody nano-
complexes in order to induce possible specific targeting.
It is difficult to control the number and location of bio-
tin residues when antibodies are chemically biotinylated.
Without a defined biotin site, chemically biotinylated
antibodies can be attached to avidin in any orientation,
often interfering with their ability to bind antigens. In
contrast, metabolically biotinylated Fab constructs can
be genetically engineered to precisely control the num-
ber and location of biotin residues on the antibody. Our
lab has developed metabolically biotinylated Fab frag-
ments against rat APP (833cb Fab) which has one biotin
residues located at the C-terminal side of the C1
domain of the heavy chain [17]. We incubated the
Ad.9RPSTCD-GFP(avidin) viral vector with 833cb Fab
and free Fab was removed by centrifugation-driven fil-
tration using a 300K molecular weight cutoff filter. The
final complexes, Ad.9RPSTCD-GFP(avidin)-833cb were
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Page 2 of 6used to transduce MA104/APP or MA104 cells, and the
GFP positive cells were counted 24 h later. As shown in
Figure 3C, Ad.9RPSTCD-GFP(avidin)-833cb transduced
the MA104/APP cells but not MA104 cells under
equivalent conditions. Thus, the transduction efficiency
of the Ad.9RPSTCD-GFP(avidin) vector can be
significantly increased through the binding to chemically
biotinylated antibodies or biotinylated Fab against speci-
fic cell surface receptors.
Construction of targeted adenoviral vector through
modification of fiber protein can be challenging because
the trimerization of modified fiber is essential for proper
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Figure 1 Structure, fiber trimerization and biotinylation of new 9RPSTCD adenoviral vector. (A) Structure of adenoviral vectors. All the
viral vectors were replication-incompetent, E1,E3-deleted vector with a GFP as reporter gene, but each vector containing different fiber genes.
The Ad.Control-GFP vector had a wild type fiber; the Ad.9R-GFP had a 9R modified fiber; the Ad.9RPSTCD-GFP had a 9R fused with PSTCD fiber.
(B) Detection of biotinylation status of different viral vectors. Equal amount of purified viral vectors were loaded on SDS-PAGE gradient gels
either boiled (B, to detect monomeric fibers) or unboiled (U, to detect trimeric fibers). The fiber protein and biotinylation were analyzed by
western blotting using antibody against fiber protein or streptavidin-HRP. All of the viral fiber proteins formed trimers but only the virus with the
PSTCD gene was biotinylated.
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Page 3 of 6virus assembly, and the retargeting ligands need to be
functional in the trimerized fiber structure. In this
report, we demonstrated that the 9RPSTCD modified
fiber can be successfully assembled onto hAd5 virus and
can be biotinylated simultaneously with viral production.
Because of the deletion of CAR-interaction, the
Ad.9RPSTCD-GFP(avidin) complex can be directed to
transduce only selected cells by binding to other cell
surface receptors through biotinylated targeting ligands.
This 9RPSTCD virus may now be suitable for high
throughput screening of targeting ligands in vitro.T h i s
vector may become useful for in vivo retargting and
screening with future modifications that reduce RES
uptake. For instance, we plan to further modify this vec-
tor by introducing the point mutation in the hexon pro-
tein to ablate the interaction of hexon with coagulation
factor FX according the methods described in reference
[7], and then evaluate RES uptake as well as possible
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Figure 2 Cell transduction was ablated in the Ad.9RPSTCD-GFP viral vector and was rescued through biotin-avidin-biotin interaction.
(A, B) The transduction efficiency of the indicated viral vectors to MA104/APP cells. Cells were collected and GFP-positive cells were counted by
flow cytometry 24 h after transduction at different MOI (viral particles/cell). (B) The transduction efficiency of the Ad.9RPSTCD-GFP(avidin) vector
to cells increased through the interaction of avidin on the Ad.9RPSTCD-GFP(avidin) vector with the biotin on the cell surface. Indicated viral
vectors were added to chemically biotinylated MA104/APP cells (bio+) or unbiotinylated MA104/APP cells (bio-), and the GFP positive cells were
counted 24 h later by flow cytometry. The data shown represent means ± SD of triplicate determinations of the GFP positive cells.
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The methods and new vectors described and character-
ized here may form a foundation for future modifica-
tions and studies attempting to further improve tissue-
and cell- specific retargeting of adenoviral vectors.
List of abbreviations used
hAd5: human adenovirus serotype 5; RES: reticuloendothelial system; CAR:
coxsackievirus B and adenovirus receptor; PSTCD: Propionibacterium
shermanii 1.3 S transcarboxylase domain; MOI: multiplicity of infection;
CsCl: cesium chloride; APP: aminopeptidase P; RAEC: rat aortic endothelial
cells.
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Figure 3 Cell transduction by Ad.9RPSTCD-GFP(avidin) through biotinylated antibodies. (A) The transduction efficiency of Ad.9RPSTCD-
GFP(avidin) vector to MA104/APP or MA104 cells preincubated with biotinylated antibodies targeting rat APP. Cells were incubated with
chemically biotinylated J310 antibodies against APP, then transduced with the viral vector. GFP positive cells were counted 24 h later. (B) The
transduction efficiency of Ad.9RPSTCD-GFP(avidin) vector to RAEC cells preincubated with chemically biotinylated J310 antibodies against APP
(non-specific) or J120 antibodies against CD34 (specific). (C) MA104/APP or MA104 cells transduced by Ad.9RPSTCD-GFP(avidin)-833cb complex.
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